Cargando…
Risk-Adapted Treatment Strategies with Pre-Irradiation Chemotherapy in Pediatric Medulloblastoma: Outcomes from the Polish Pediatric Neuro-Oncology Group
Craniospinal irradiation (CSI) has been a major component of the standard of care treatment backbone for childhood medulloblastoma. However, chemotherapy regimens have varied based on protocol, patient age, and molecular subtyping. In one of the largest studies to date, we analyzed treatment outcome...
Autores principales: | Perek-Polnik, Marta, Cochrane, Anne, Wang, Jinli, Chojnacka, Marzanna, Drogosiewicz, Monika, Filipek, Iwona, Swieszkowska, Ewa, Tarasinska, Magdalena, Grajkowska, Wiesława, Trubicka, Joanna, Kowalczyk, Paweł, Dembowska-Bagińskai, Bożenna, Abdelbaki, Mohamed S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453075/ https://www.ncbi.nlm.nih.gov/pubmed/37628386 http://dx.doi.org/10.3390/children10081387 |
Ejemplares similares
-
MEDB-26. Outcomes of children with standard-risk and high-risk medulloblastoma treated with pre-irradiation chemotherapy and risk-adapted craniospinal irradiation: a report on patients from the Polish Pediatric Neuro-oncology Group
por: Perek-Polnik, Marta, et al.
Publicado: (2022) -
Immunohistochemical detection of ALK protein identifies APC mutated medulloblastoma and differentiates the WNT-activated medulloblastoma from other types of posterior fossa childhood tumors
por: Łastowska, Maria, et al.
Publicado: (2018) -
The germline variants in DNA repair genes in pediatric medulloblastoma: a challenge for current therapeutic strategies
por: Trubicka, Joanna, et al.
Publicado: (2017) -
Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours
por: Łastowska, Maria, et al.
Publicado: (2015) -
Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis
por: Łastowska, Maria, et al.
Publicado: (2018)